Advisornet Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $208K | Buy |
981
+254
| +35% | +$49.9K | 0.01% | 643 |
|
|
2026
Q1 | $142K | Buy |
727
+8
| +1% | +$1.55K | 0.01% | 709 |
|
|
2025
Q4 | $125K | Sell |
719
-404
| -36% | -$73.6K | 0.01% | 736 |
|
|
2025
Q3 | $214K | Sell |
1,123
-170
| -13% | -$30.2K | 0.01% | 579 |
|
|
2025
Q2 | $232K | Sell |
1,293
-166
| -11% | -$28.8K | 0.02% | 532 |
|
|
2025
Q1 | $247K | Buy |
1,459
+11
| +0.8% | +$1.81K | 0.02% | 497 |
|
|
2024
Q4 | $218K | Buy |
1,448
+4
| +0.3% | +$622 | 0.02% | 485 |
|
|
2024
Q3 | $224K | Buy |
1,444
+689
| +91% | +$103K | 0.02% | 500 |
|
|
2024
Q2 | $103K | Buy |
755
+2
| +0.3% | +$274 | 0.01% | 631 |
|
|
2024
Q1 | $100K | Sell |
753
-38
| -5% | -$4.93K | 0.01% | 637 |
|
|
2023
Q4 | $109K | Buy |
791
+22
| +3% | +$2.89K | 0.01% | 619 |
|
|
2023
Q3 | $93.7K | Sell |
769
-122
| -14% | -$16.3K | 0.01% | 637 |
|
|
2023
Q2 | $125K | Sell |
891
-45
| -5% | -$6.2K | 0.01% | 586 |
|
|
2023
Q1 | $132K | Sell |
936
-55
| -6% | -$7.87K | 0.01% | 557 |
|
|
2022
Q4 | $155K | Buy |
991
+24
| +2% | +$3.45K | 0.02% | 529 |
|
|
2022
Q3 | $119K | Buy |
967
+18
| +2% | +$2.37K | 0.01% | 618 |
|
|
2022
Q2 | $126K | Sell |
949
-196
| -17% | -$26.7K | 0.01% | 606 |
|
|
2022
Q1 | $157K | Sell |
1,145
-2
| -0.2% | -$279 | 0.01% | 620 |
|
|
2021
Q4 | $198K | Buy |
1,147
+9
| +0.8% | +$1.37K | 0.01% | 606 |
|
|
2021
Q3 | $165K | Buy |
1,138
+3
| +0.3% | +$439 | 0.01% | 640 |
|
|
2021
Q2 | $150K | Buy |
1,135
+3
| +0.3% | +$393 | 0.01% | 677 |
|
|
2021
Q1 | $145K | Sell |
1,132
-296
| -21% | -$36.5K | 0.01% | 646 |
|
|
2020
Q4 | $170K | Buy |
1,428
+20
| +1% | +$2.44K | 0.01% | 539 |
|
|
2020
Q3 | $161K | Sell |
1,408
-211
| -13% | -$24.9K | 0.01% | 539 |
|
|
2020
Q2 | $185K | Buy |
1,619
+690
| +74% | +$73.2K | 0.01% | 507 |
|
|
2020
Q1 | $75K | Buy |
929
+194
| +26% | +$20.1K | 0.01% | 682 |
|
|
2019
Q4 | $78K | Buy |
735
+288
| +64% | +$30K | 0.01% | 751 |
|
|
2019
Q3 | $48K | Buy |
447
+1
| +0.2% | +$103 | ﹤0.01% | 922 |
|
|
2019
Q2 | $45K | Buy |
446
+1
| +0.2% | +$96 | 0.01% | 832 |
|
|
2019
Q1 | $40K | Buy |
445
+57
| +15% | +$4.94K | ﹤0.01% | 790 |
|
|
2018
Q4 | $32K | Sell |
388
-62
| -14% | -$5.81K | ﹤0.01% | 796 |
|
|
2018
Q3 | $49K | Hold |
450
| – | – | 0.01% | 724 |
|
|
2018
Q2 | $49K | Buy |
450
+201
| +81% | +$20.9K | 0.01% | 703 |
|
|
2018
Q1 | $25K | Buy |
249
+74
| +42% | +$7.58K | ﹤0.01% | 878 |
|
|
2017
Q4 | $17K | Buy |
+175
| New | +$16.6K | ﹤0.01% | 894 |
|
Other funds holding DGX
EIG
Advisornet Financial's DGX Position: Q2 2026 in Review
Advisornet Financial increased its Quest Diagnostics (DGX) stake by 35% in Q2 2026, buying an estimated $49.9K and bringing the position to 981 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #643.
Advisornet Financial first reported a position in DGX in Q4 2017 and has held it in 35 quarters since. The position peaked at $247K in Q1 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Advisornet Financial held 981 shares of Quest Diagnostics worth $208K as of Q2 2026.
- Advisornet Financial bought 254 Quest Diagnostics shares in Q2 2026, an estimated $49.9K.
- Quest Diagnostics made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #643 holding.
- Advisornet Financial first reported a position in Quest Diagnostics in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Quest Diagnostics position peaked at $247K in Q1 2025.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.